Miho Inoue

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

Yoshiya Kawaguchi, Toshihiro Okamoto, Masafumi Taniwaki et al. · Nature Genetics · 1994 · 1.8K citations

Life Sciences, Genetics, Molecular Genetics +11

Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types

Yutaka Kanda, Tsuyoshi Yamada, Katsuhiro Mori et al. · Glycobiology · 2006 · 375 citations

Pharmacy, Biochemistry, Immunology +17

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

Folefac Aminkeng, Amit P. Bhavsar, Henk Visscher et al. · Nature Genetics · 2015 · 275 citations · Full text

Medicine, Cardiology, Oncology +17

Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa

Shigeru Iida, Hirofumi Misaka, Miho Inoue et al. · Clinical Cancer Research · 2006 · 206 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Double knockdown of α1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC

Harue Imai-Nishiya, Katsuhiro Mori, Miho Inoue et al. · BMC Biotechnology · 2007 · 156 citations · Full text

Medicine, Biochemistry, Oncology +15